{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.5043","meta":{"versionId":"5","lastUpdated":"2020-09-14T14:34:23.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5043","version":"20200724","name":"SARS Coronavirus 2 IgA  IgM Combined, Qualitative","status":"active","date":"2020-07-24T01:00:35-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://loinc.org","version":"2.72","concept":[{"code":"95125-1","display":"SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay"}]}]},"expansion":{"identifier":"urn:uuid:64828d4c-0d5a-4772-9a28-df5341ea6285","timestamp":"2022-06-10T11:46:51-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://loinc.org","version":"2.72","code":"95125-1","display":"SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay"}]}}